Navigation Links
Study finds flame retardants at high levels in pet dogs
Date:4/25/2011

BLOOMINGTON, Ind. -- Indiana University scientists have found chemical flame retardants in the blood of pet dogs at concentrations five to 10 times higher than in humans, but lower than levels found in a previous study of cats.

Their study, "Flame Retardants in the Serum of Pet Dogs and in their Food," appears this month in the journal Environmental Science & Technology. Authors are Marta Venier, an assistant research scientist in the School of Public and Environmental Affairs, and Ronald Hites, a Distinguished Professor in SPEA.

Venier and Hites explore whether pets could serve as "biosentinels" for monitoring human exposure to compounds present in the households that they share. Dogs may be better proxies than cats, they say, because a dog's metabolism is better equipped to break down the chemicals.

The study focuses on the presence of polybrominated diphenyl ethers (PBDEs) in the blood of dogs and in commercial dog food. PBDEs have been widely used as flame retardants in household furniture and electronics equipment. The compounds can migrate out of the products and enter the environment.

"Even though they've been around for quite awhile, we don't know too much about these compounds' toxicological effects on humans or animals," Venier said. "The bottom line is that we still need to keep measuring them, particularly in homes."

PBDE mixtures made up of less-brominated compounds are regarded as more dangerous because they bioaccumulate in animal tissues. These mixtures were banned by the European Union and were voluntarily removed from the U.S. market in 2004, but remain in the environment. Mixtures with more-brominated compounds remain in use in the U.S. but will be phased out by 2013.

Venier and Hites report on an analysis of flame retardants in blood from 17 pet dogs, all of whom live primarily indoors. They also examined samples of the dry dog food that made up the pets' diet, attempting to determine if food was a major source of PBDE exposure.

The average concentration of PBDEs in blood from the dogs was about 2 nanograms per gram, about five to 10 times higher than the levels found in humans in the few studies of human exposure that have been done in North America.

In dog food samples, the researchers found PBDEs at levels averaging about 1 nanogram per gram. That is much higher than levels found in meat and poultry sold as food for humans, suggesting the PBDEs in dog food may result from processing rather than from the food sources.

A 2007 study by Venier, Hites and several co-authors found concentrations of PBDEs in house cats that were 20 to 100 times higher than levels found in humans. A 2010 article by Venier, Hites and two Clemson University researchers also reported high levels of PBDEs in nesting bald eagles.

Venier said the evidence shows dogs metabolize the compounds more rapidly than cats. A previous study showed that dogs produce an enzyme that breaks down organochlorine pesticides, and a similar mechanism may be at work with brominated compounds.

The current study also detected newer flame retardants that have come onto the market as PBDEs have been removed, including Dechlorane Plus, decabromodiphenylethane, and hexabromocyclododecane. The chemicals are largely unregulated but pose concerns because they are structurally similar to organic pollutants that have been linked to environmental and human health effects.

"The concentrations of these newer flame retardants were relatively low compared to the PBDEs," Venier said, "but the fact that they are new and not regulated suggests their levels are going to increase in the future."


'/>"/>

Contact: Steve Hinnefeld
slhinnef@indiana.edu
812-856-3488
Indiana University
Source:Eurekalert

Related biology news :

1. Study: Reasonable quantities of red pepper may help curb appetite
2. Study shows how mosquitoes handle the heat of a hot blood meal
3. Study in roundworm chromosomes may offer new clues to tumor genome development
4. Gulf oil spill similar to Exxon Valdez in initial social and mental impacts, study finds
5. Study of deer mice on Californias Channel Islands provides new information on hantavirus
6. VIMS study: Propeller turbulence may affect marine food webs
7. Reptilian root canal: U of T Mississauga study reveals infection in jaw of ancient fossil
8. Nationwide study finds US meat and poultry is widely contaminated
9. New study finds stronger regulations of in vitro fertilization may save lives
10. Study: Algae could replace 17 percent of US oil imports
11. Scots carbon emissions could be halved in decades, study suggests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2016)... MINNETONKA, Minn. , Nov. 22, 2016   ... that supports the entire spectrum of clinical research, is ... by Medical LiveWire Healthcare and Life Sciences Awards ... This award caps off an unprecedented year of recognition ... clinical trials for over 15 years. iMedNet ...
(Date:11/17/2016)... -- Global Market Watch: Primarily supported by ownership ... and Academics) market is to witness a value of US$37.1 ... highest Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen ... period 2014-2020. North America is not ... Europe at 9.56% respectively. Report Focus: ...
(Date:11/15/2016)... ROCKVILLE, Md. , Nov. 15, 2016 /PRNewswire/ ... clinical company developing therapeutics focused on the gut ... public offering of 25,000,000 shares of its common ... its common stock at a price to the ... gross proceeds to Synthetic Biologics from the offering, ...
Breaking Biology News(10 mins):
(Date:12/4/2016)... ... 03, 2016 , ... Microbial genomics leader uBiome is awarding ... been made to Dr. Renato Polimanti of Yale University School of Medicine, who ... Grant proposals have been vetted by the company’s scientific review committee. , ...
(Date:12/2/2016)... ... 2016 , ... In anticipation of AxioMed’s exclusive cleanroom manufacturing ... President, Jake Lubinski will be traveling to Switzerland from December 5-10. Mr. Lubinski ... and Zurich to discuss the benefits of a viscoelastic disc. AxioMed received CE ...
(Date:12/2/2016)... Amgen (NASDAQ: AMGN ) and Allergan ... of a Marketing Authorization Application (MAA) to the European Medicines ... ® (bevacizumab). The companies believe this submission is the ... "The submission of ABP 215 to the EMA is ... portfolio," said Sean E. Harper , M.D., executive vice ...
(Date:12/2/2016)... ... 2016 , ... ACEA Biosciences, Inc. announced today that it will be presenting ... the World Conference on Lung Cancer 2016, taking place in Vienna, Austria December 3rd-8th. ... trials for AC0010 in patients with advanced non-small cell lung cancer harboring the EGFR ...
Breaking Biology Technology: